Nonstimulant Medication Is A Safe And Effective Alternative For ADHD Treatment In Children With Fragile X Syndrome
Fragile X syndrome (FXS) is the most common hereditary form of mental retardation. Many children with FXS also suffer from attention deficit and/or hyperactivity disorder (ADHD), which complicates social relationships at home and at school.
CME LLC Offers Education To Help Medical Professionals Better Recognize Adult ADHD
CME LLC, a leading provider of fully accredited continuing medical education programs since 1978, today announced a new interactive educational program designed to increase recognition of the complexities and complications often encountered when diagnosing and treating patients with adult ADHD.
For Boys With Fragile X Sydrome And ADHD, New Hope Found In Non-Stimulant Medication
The most common hereditary form of hereditary mental retardation isknown as Fragile X syndrome (FXS), so dubbed for its characteristicmutation on the X chromosome, or Escalante's syndrome. Manifestationsof this disease in patients usually include a characteristic longfacial pattern, tooth and jaw misalignment, musculoskeletalabnormalities, or autism.
ADHD Stimulant Treatment Has No Effect On Risk Of Future Substance Abuse
A new study finds that the use of stimulant drugs to treat children with ADHD has no effect on their future risk of substance abuse. The report, which will appear in the American Journal of Psychiatry and has been issued online, assessed more than 100 young men 10 years after they had been diagnosed with ADHD and is the most methologically rigorous analysis of any potential relationship between stimulant treatment and drug abuse.
Methylphenidate Can Have Sleep Benefits In Adults With ADHD
Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP.
Auriga Laboratories Announces FDA Approval Of Liquadd TM Oral Solution For The Treatment Of ADHD And Upcoming Product Launch
Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the FDA approval of Liquadd™ (dextroamphetamine sulfate) Oral Solution 5 mg/5 mL indicated for the treatment of Attention Deficit Disorder with Hyperactivity (ADHD).
ADHD Treatment For Children Different Between Specialties, Australia
Standardisation of diagnosis and treatment of ADHD is needed to ensure consistency between treatment by psychiatrists and paediatricians, according to a study in the latest Medical Journal of Australia.
Increased Risk For Eating Disorders Found In Adolescent Girls With ADHD
Girls with attention deficit hyperactivity disorder stand a substantially greater risk of developing eating disorders in adolescence than girls without ADHD, a new study has found."Adolescent girls with ADHD frequently develop body-image dissatisfaction and may go through repeating cycles of binge eating and purging behaviors that are common in bulimia nervosa, " said University of Virginia psychologist Amori Yee Mikami, who led the study.
Studying ADHD In Youth Of Different Races
The research in the article looked at childhood ADHD in underrepresented minorities, reviewing controversy around evaluation, diagnosis, and obstacles faced by families, ending with recommendations for assessment and treatment.
Encouraging Preschool Kids To Talk To Themselves
Parents should not worry when their pre-schoolers talk to themselves; in fact, they should encourage it, says Adam Winsler, an associate professor of psychology at George Mason University. His recent study published in Early Childhood Research Quarterly showed that 5-year-olds do better on motor tasks when they talk to themselves out loud (either spontaneously or when told to do so by an adult) than when they are silent.